Brain stem cell implant trial offers new hope for Parkinson's
NCT ID NCT07106021
First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This early-stage trial tests a new treatment called RNDP-001, which involves transplanting dopamine-producing stem cells into the brains of 12 people with Parkinson's disease. The main goal is to see if the procedure is safe and tolerable. Researchers will also monitor changes in movement quality and brain scans over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON´S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Keck Medical Center of University of Southern California
Los Angeles, California, 90033, United States
-
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
University of Arizona
Tucson, Arizona, 85721, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.